Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment
Authors:
- Per JessPJPer Jess
- Ole RoikjaerOROle Roikjaer
- 1 September 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 58 (9) , 823-830
Abstract
It has been proposed that the lymph node yield achieved during rectal cancer resection is associated with survival. It is debated whether a high lymph node yield improves survival, per se, or whether it does so by diminishing the International Union Against Cancer stage drifting effect. The purpose of this study was to evaluate the prognostic implications of the lymph node yield in curative resected rectal cancer. This study was based on data from a prospectively maintained colorectal cancer database. This was a national cohort study. All 6793 patients in Denmark who were diagnosed with International Union Against Cancer stage I to III adenocarcinoma of the rectum and so treated in the period from 2003 to 2011 were included in the analysis. The primary outcome measure was overall survival. The observed percentages of patients with International Union Against Cancer stage III disease with a lymph node yield less than 12 or 12 or more were 28.1 % and 40.7% (p < 0.0001) in the non-neoadjuvant treatment group and 26.9% and 38.3% (p < 0.0001) in the neoadjuvant treatment group. The 5-year overall survival rates for patients with a lymph node yield <12 or 12 or more were 73.1% and 80.6% in International Union Against Cancer stages I to II (p < 0.0001) and 57.4% and 53.3% in stage III (p < 0.142) in the neoadjuvant treatment group and 70.4% and 79.2% in stages I to II (p < 0.0001) and 46.6% and 59.1% in International Union Against Cancer stage III (p < 0.0001) in the non-neoadjuvant treatment group. In multivariate analysis, the lymph node yield turned out to be an independent prognostic factor, irrespective of neoadjuvant treatment. It is not possible in an observational study to tell whether the findings are associations rather than causal relationships. Increased lymph node yield was associated with better overall survival in rectal cancer, irrespective of neoadjuvant treatment. Stage migration was observed.Keywords
This publication has 6 references indexed in Scilit:
- Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based studyThe Lancet Oncology, 2015
- Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancerBritish Journal of Surgery, 2013
- Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinomaCancer, 2011
- Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologistsBritish Journal of Cancer, 2006
- Number of lymph nodes examined and prognosis of TNM stage II colorectal cancerEuropean Journal of Cancer, 2005
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001